3.24.2.u1 html 286 447 1 true 108 0 false 7 false false R1.htm 000100 - Document - Document and Entity Information Sheet http://serestherapeutics.com/role/DocumentAndEntityInformation Document and Entity Information Cover 1 false false R2.htm 010000 - Statement - Consolidated Balance Sheets Sheet http://serestherapeutics.com/role/ConsolidatedBalanceSheets Consolidated Balance Sheets Statements 2 false false R3.htm 010100 - Statement - Consolidated Balance Sheets (Parenthetical) Sheet http://serestherapeutics.com/role/ConsolidatedBalanceSheetsParenthetical Consolidated Balance Sheets (Parenthetical) Statements 3 false false R4.htm 020000 - Statement - Consolidated Statements of Operations and Comprehensive Loss Sheet http://serestherapeutics.com/role/ConsolidatedStatementsOfOperationsAndComprehensiveLoss Consolidated Statements of Operations and Comprehensive Loss Statements 4 false false R5.htm 020100 - Statement - Consolidated Statements of Operations and Comprehensive Loss (Parenthetical) Sheet http://serestherapeutics.com/role/ConsolidatedStatementsOfOperationsAndComprehensiveLossParenthetical Consolidated Statements of Operations and Comprehensive Loss (Parenthetical) Statements 5 false false R6.htm 030000 - Statement - Consolidated Statements of Stockholders' (Deficit) Equity Sheet http://serestherapeutics.com/role/ConsolidatedStatementsOfStockholdersDeficitEquity Consolidated Statements of Stockholders' (Deficit) Equity Statements 6 false false R7.htm 040000 - Statement - Condensed Consolidated Statement of Stockholders' (Deficit) Equity (Parenthetical) Sheet http://serestherapeutics.com/role/CondensedConsolidatedStatementOfStockholdersDeficitEquityParenthetical Condensed Consolidated Statement of Stockholders' (Deficit) Equity (Parenthetical) Statements 7 false false R8.htm 050000 - Statement - Consolidated Statements of Cash Flows Sheet http://serestherapeutics.com/role/ConsolidatedStatementsOfCashFlows Consolidated Statements of Cash Flows Statements 8 false false R9.htm 050100 - Statement - Consolidated Statements of Cash Flows (Parenthetical) Sheet http://serestherapeutics.com/role/ConsolidatedStatementsOfCashFlowsParenthetical Consolidated Statements of Cash Flows (Parenthetical) Statements 9 false false R10.htm 060100 - Disclosure - Nature of the Business and Basis of Presentation Sheet http://serestherapeutics.com/role/NatureOfBusinessAndBasisOfPresentation Nature of the Business and Basis of Presentation Notes 10 false false R11.htm 060200 - Disclosure - Summary of Significant Accounting Policies Sheet http://serestherapeutics.com/role/SummaryOfSignificantAccountingPolicies Summary of Significant Accounting Policies Notes 11 false false R12.htm 060300 - Disclosure - Fair Value of Financial Assets and Liabilities Sheet http://serestherapeutics.com/role/FairValueOfFinancialAssetsAndLiabilities Fair Value of Financial Assets and Liabilities Notes 12 false false R13.htm 060400 - Disclosure - Investments Sheet http://serestherapeutics.com/role/Investments Investments Notes 13 false false R14.htm 060500 - Disclosure - Inventories Sheet http://serestherapeutics.com/role/Inventories Inventories Notes 14 false false R15.htm 060600 - Disclosure - Property and Equipment, Net Sheet http://serestherapeutics.com/role/PropertyAndEquipmentNet Property and Equipment, Net Notes 15 false false R16.htm 060700 - Disclosure - Accrued Expenses and Other Current Liabilities Sheet http://serestherapeutics.com/role/AccruedExpensesAndOtherCurrentLiabilities Accrued Expenses and Other Current Liabilities Notes 16 false false R17.htm 060800 - Disclosure - Leases Sheet http://serestherapeutics.com/role/Leases Leases Notes 17 false false R18.htm 060900 - Disclosure - Notes Payable Notes http://serestherapeutics.com/role/NotesPayable Notes Payable Notes 18 false false R19.htm 061000 - Disclosure - Preferred Stock Sheet http://serestherapeutics.com/role/PreferredStock Preferred Stock Notes 19 false false R20.htm 061100 - Disclosure - Common Stock and Stock-Based Awards Sheet http://serestherapeutics.com/role/CommonStockAndStockbasedAwards Common Stock and Stock-Based Awards Notes 20 false false R21.htm 061200 - Disclosure - Net Loss per Share Sheet http://serestherapeutics.com/role/NetLossPerShare Net Loss per Share Notes 21 false false R22.htm 061300 - Disclosure - Restructuring Sheet http://serestherapeutics.com/role/Restructuring Restructuring Notes 22 false false R23.htm 061400 - Disclosure - Revenue from Contracts with Customers Sheet http://serestherapeutics.com/role/RevenueFromContractsWithCustomers Revenue from Contracts with Customers Notes 23 false false R24.htm 061500 - Disclosure - Collaboration Profit and Loss Sheet http://serestherapeutics.com/role/CollaborationProfitAndLoss Collaboration Profit and Loss Notes 24 false false R25.htm 061600 - Disclosure - Commitments and Contingencies Sheet http://serestherapeutics.com/role/CommitmentsAndContingencies Commitments and Contingencies Notes 25 false false R26.htm 061700 - Disclosure - Income Taxes Sheet http://serestherapeutics.com/role/IncomeTaxes Income Taxes Notes 26 false false R27.htm 061800 - Disclosure - Related Party Transactions Sheet http://serestherapeutics.com/role/RelatedPartyTransactions Related Party Transactions Notes 27 false false R28.htm 061900 - Disclosure - 401(k) Savings Plan Sheet http://serestherapeutics.com/role/KSavingsPlan 401(k) Savings Plan Notes 28 false false R29.htm 070200 - Disclosure - Summary of Significant Accounting Policies (Policies) Sheet http://serestherapeutics.com/role/SummaryOfSignificantAccountingPoliciesPolicies Summary of Significant Accounting Policies (Policies) Policies http://serestherapeutics.com/role/SummaryOfSignificantAccountingPolicies 29 false false R30.htm 080200 - Disclosure - Summary of Significant Accounting Policies (Tables) Sheet http://serestherapeutics.com/role/SummaryOfSignificantAccountingPoliciesTables Summary of Significant Accounting Policies (Tables) Tables http://serestherapeutics.com/role/SummaryOfSignificantAccountingPolicies 30 false false R31.htm 080300 - Disclosure - Fair Value of Financial Assets and Liabilities (Tables) Sheet http://serestherapeutics.com/role/FairValueOfFinancialAssetsAndLiabilitiesTables Fair Value of Financial Assets and Liabilities (Tables) Tables http://serestherapeutics.com/role/FairValueOfFinancialAssetsAndLiabilities 31 false false R32.htm 080400 - Disclosure - Investments (Tables) Sheet http://serestherapeutics.com/role/InvestmentsTables Investments (Tables) Tables http://serestherapeutics.com/role/Investments 32 false false R33.htm 080500 - Disclosure - Inventories (Tables) Sheet http://serestherapeutics.com/role/InventoriesTables Inventories (Tables) Tables http://serestherapeutics.com/role/Inventories 33 false false R34.htm 080600 - Disclosure - Property and Equipment, Net (Tables) Sheet http://serestherapeutics.com/role/PropertyAndEquipmentNetTables Property and Equipment, Net (Tables) Tables http://serestherapeutics.com/role/PropertyAndEquipmentNet 34 false false R35.htm 080700 - Disclosure - Accrued Expenses and Other Current Liabilities (Tables) Sheet http://serestherapeutics.com/role/AccruedExpensesAndOtherCurrentLiabilitiesTables Accrued Expenses and Other Current Liabilities (Tables) Tables http://serestherapeutics.com/role/AccruedExpensesAndOtherCurrentLiabilities 35 false false R36.htm 080800 - Disclosure - Leases (Tables) Sheet http://serestherapeutics.com/role/LeasesTables Leases (Tables) Tables http://serestherapeutics.com/role/Leases 36 false false R37.htm 080900 - Disclosure - Notes Payable (Tables) Notes http://serestherapeutics.com/role/NotesPayableTables Notes Payable (Tables) Tables http://serestherapeutics.com/role/NotesPayable 37 false false R38.htm 081100 - Disclosure - Common Stock and Stock-Based Awards (Tables) Sheet http://serestherapeutics.com/role/CommonStockAndStockbasedAwardsTables Common Stock and Stock-Based Awards (Tables) Tables http://serestherapeutics.com/role/CommonStockAndStockbasedAwards 38 false false R39.htm 081200 - Disclosure - Net Loss per Share (Tables) Sheet http://serestherapeutics.com/role/NetLossPerShareTables Net Loss per Share (Tables) Tables http://serestherapeutics.com/role/NetLossPerShare 39 false false R40.htm 081300 - Disclosure - Restructuring (Tables) Sheet http://serestherapeutics.com/role/RestructuringTables Restructuring (Tables) Tables http://serestherapeutics.com/role/Restructuring 40 false false R41.htm 081400 - Disclosure - Revenue from Contracts with Customers (Tables) Sheet http://serestherapeutics.com/role/RevenueFromContractsWithCustomersTables Revenue from Contracts with Customers (Tables) Tables http://serestherapeutics.com/role/RevenueFromContractsWithCustomers 41 false false R42.htm 081500 - Disclosure - Collaboration Profit and Loss (Tables) Sheet http://serestherapeutics.com/role/CollaborationProfitAndLossTables Collaboration Profit and Loss (Tables) Tables http://serestherapeutics.com/role/CollaborationProfitAndLoss 42 false false R43.htm 081700 - Disclosure - Income Taxes (Tables) Sheet http://serestherapeutics.com/role/IncomeTaxesTables Income Taxes (Tables) Tables http://serestherapeutics.com/role/IncomeTaxes 43 false false R44.htm 090100 - Disclosure - Nature of the Business and Basis of Presentation - Additional Information (Details) Sheet http://serestherapeutics.com/role/NatureOfBusinessAndBasisOfPresentationAdditionalInformationDetails Nature of the Business and Basis of Presentation - Additional Information (Details) Details 44 false false R45.htm 090200 - Disclosure - Summary of Significant Accounting Policies - Additional Information (Details) Sheet http://serestherapeutics.com/role/SummaryOfSignificantAccountingPoliciesAdditionalInformationDetails Summary of Significant Accounting Policies - Additional Information (Details) Details 45 false false R46.htm 090202 - Disclosure - Summary of Significant Accounting Policies - Cash, Cash Equivalents and Restricted Cash (Details) Sheet http://serestherapeutics.com/role/SummaryOfSignificantAccountingPoliciesCashCashEquivalentsAndRestrictedCashDetails Summary of Significant Accounting Policies - Cash, Cash Equivalents and Restricted Cash (Details) Details 46 false false R47.htm 090204 - Disclosure - Summary of Significant Accounting Policies - Schedule of Property and Equipment Estimated Useful Life (Details) Sheet http://serestherapeutics.com/role/SummaryOfSignificantAccountingPoliciesScheduleOfPropertyAndEquipmentEstimatedUsefulLifeDetails Summary of Significant Accounting Policies - Schedule of Property and Equipment Estimated Useful Life (Details) Details 47 false false R48.htm 090300 - Disclosure - Fair Value of Financial Assets and Liabilities - Summary of Fair Value Hierarchy for Assets and Liabilities Measured at Fair Value on Recurring Basis (Details) Sheet http://serestherapeutics.com/role/FairValueOfFinancialAssetsAndLiabilitiesSummaryOfFairValueHierarchyForAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetails Fair Value of Financial Assets and Liabilities - Summary of Fair Value Hierarchy for Assets and Liabilities Measured at Fair Value on Recurring Basis (Details) Details 48 false false R49.htm 090302 - Disclosure - Fair Value of Financial Assets and Liabilities - Additional Information (Details) Sheet http://serestherapeutics.com/role/FairValueOfFinancialAssetsAndLiabilitiesAdditionalInformationDetails Fair Value of Financial Assets and Liabilities - Additional Information (Details) Details 49 false false R50.htm 090304 - Disclosure - Fair Value of Financial Assets and Liabilities - Schedule of Level 3 Inputs to Warrant Liabilities (Details) Sheet http://serestherapeutics.com/role/FairValueOfFinancialAssetsAndLiabilitiesScheduleOfLevel3InputsToWarrantLiabilitiesDetails Fair Value of Financial Assets and Liabilities - Schedule of Level 3 Inputs to Warrant Liabilities (Details) Details 50 false false R51.htm 090306 - Disclosure - Fair Value of Financial Assets and Liabilities - Schedule of Reconciliation Company's Liabilities Measured at Fair Value on Recurring Basis (Details) Sheet http://serestherapeutics.com/role/FairValueOfFinancialAssetsAndLiabilitiesScheduleOfReconciliationCompanySLiabilitiesMeasuredAtFairValueOnRecurringBasisDetails Fair Value of Financial Assets and Liabilities - Schedule of Reconciliation Company's Liabilities Measured at Fair Value on Recurring Basis (Details) Details 51 false false R52.htm 090400 - Disclosure - Investments - Schedule of Investments by Security Type (Details) Sheet http://serestherapeutics.com/role/InvestmentsScheduleOfInvestmentsBySecurityTypeDetails Investments - Schedule of Investments by Security Type (Details) Details 52 false false R53.htm 090402 - Disclosure - Investments - Additional Information (Details) Sheet http://serestherapeutics.com/role/InvestmentsAdditionalInformationDetails Investments - Additional Information (Details) Details 53 false false R54.htm 090500 - Disclosure - Inventories - Schedule of Capitalized Inventories (Details) Sheet http://serestherapeutics.com/role/InventoriesScheduleOfCapitalizedInventoriesDetails Inventories - Schedule of Capitalized Inventories (Details) Details 54 false false R55.htm 090502 - Disclosure - Inventories - Additional Information (Details) Sheet http://serestherapeutics.com/role/InventoriesAdditionalInformationDetails Inventories - Additional Information (Details) Details 55 false false R56.htm 090600 - Disclosure - Property and Equipment, Net - Schedule of Property and Equipment, Net (Details) Sheet http://serestherapeutics.com/role/PropertyAndEquipmentNetScheduleOfPropertyAndEquipmentNetDetails Property and Equipment, Net - Schedule of Property and Equipment, Net (Details) Details 56 false false R57.htm 090602 - Disclosure - Property and Equipment, Net - Additional Information (Details) Sheet http://serestherapeutics.com/role/PropertyAndEquipmentNetAdditionalInformationDetails Property and Equipment, Net - Additional Information (Details) Details 57 false false R58.htm 090700 - Disclosure - Accrued Expenses and Other Current Liabilities - Summary of Accrued Expenses and Other Current Liabilities (Details) Sheet http://serestherapeutics.com/role/AccruedExpensesAndOtherCurrentLiabilitiesSummaryOfAccruedExpensesAndOtherCurrentLiabilitiesDetails Accrued Expenses and Other Current Liabilities - Summary of Accrued Expenses and Other Current Liabilities (Details) Details 58 false false R59.htm 090702 - Disclosure - Accrued Expenses and Other Current Liabilities - Additional Information (Details) Sheet http://serestherapeutics.com/role/AccruedExpensesAndOtherCurrentLiabilitiesAdditionalInformationDetails Accrued Expenses and Other Current Liabilities - Additional Information (Details) Details 59 false false R60.htm 090800 - Disclosure - Leases - Additional Information (Details) Sheet http://serestherapeutics.com/role/LeasesAdditionalInformationDetails Leases - Additional Information (Details) Details 60 false false R61.htm 090802 - Disclosure - Leases - Summary of Operating Lease Assets and Liabilities (Details) Sheet http://serestherapeutics.com/role/LeasesSummaryOfOperatingLeaseAssetsAndLiabilitiesDetails Leases - Summary of Operating Lease Assets and Liabilities (Details) Details 61 false false R62.htm 090804 - Disclosure - Leases - Summary of Lease Costs (Details) Sheet http://serestherapeutics.com/role/LeasesSummaryOfLeaseCostsDetails Leases - Summary of Lease Costs (Details) Details 62 false false R63.htm 090806 - Disclosure - Leases - Schedule of Future Payments of Operating Lease Liabilities (Details) Sheet http://serestherapeutics.com/role/LeasesScheduleOfFuturePaymentsOfOperatingLeaseLiabilitiesDetails Leases - Schedule of Future Payments of Operating Lease Liabilities (Details) Details 63 false false R64.htm 090900 - Disclosure - Notes Payable - Additional Information (Details) Notes http://serestherapeutics.com/role/NotesPayableAdditionalInformationDetails Notes Payable - Additional Information (Details) Details 64 false false R65.htm 090902 - Disclosure - Notes Payable - Additional Information 1 (Details) Notes http://serestherapeutics.com/role/NotesPayableAdditionalInformation1Details Notes Payable - Additional Information 1 (Details) Details 65 false false R66.htm 090904 - Disclosure - Notes Payable - Summary of Future Principal Payments Due Under Arrangement, Excluding Interest and End of Term Charge (Details) Notes http://serestherapeutics.com/role/NotesPayableSummaryOfFuturePrincipalPaymentsDueUnderArrangementExcludingInterestAndEndOfTermChargeDetails Notes Payable - Summary of Future Principal Payments Due Under Arrangement, Excluding Interest and End of Term Charge (Details) Details 66 false false R67.htm 091000 - Disclosure - Preferred Stock - Additional Information (Details) Sheet http://serestherapeutics.com/role/PreferredStockAdditionalInformationDetails Preferred Stock - Additional Information (Details) Details 67 false false R68.htm 091100 - Disclosure - Common Stock and Stock-Based Awards - Additional Information (Details) Sheet http://serestherapeutics.com/role/CommonStockAndStockbasedAwardsAdditionalInformationDetails Common Stock and Stock-Based Awards - Additional Information (Details) Details 68 false false R69.htm 091102 - Disclosure - Common Stock and Stock-Based Awards - 2012 Stock Incentive plan - Additional Information (Details) Sheet http://serestherapeutics.com/role/CommonStockAndStockbasedAwards2012StockIncentivePlanAdditionalInformationDetails Common Stock and Stock-Based Awards - 2012 Stock Incentive plan - Additional Information (Details) Details 69 false false R70.htm 091104 - Disclosure - Common Stock and Stock-Based Awards - 2015 Incentive Award Plan - Additional Information (Details) Sheet http://serestherapeutics.com/role/CommonStockAndStockbasedAwards2015IncentiveAwardPlanAdditionalInformationDetails Common Stock and Stock-Based Awards - 2015 Incentive Award Plan - Additional Information (Details) Details 70 false false R71.htm 091106 - Disclosure - Common Stock and Stock-Based Awards - 2015 Employee Stock Purchase Plan - Additional Information (Details) Sheet http://serestherapeutics.com/role/CommonStockAndStockbasedAwards2015EmployeeStockPurchasePlanAdditionalInformationDetails Common Stock and Stock-Based Awards - 2015 Employee Stock Purchase Plan - Additional Information (Details) Details 71 false false R72.htm 091108 - Disclosure - Common Stock and Stock-Based Awards - 2022 Employment Inducement Award Plan - Additional Information (Details) Sheet http://serestherapeutics.com/role/CommonStockAndStockbasedAwards2022EmploymentInducementAwardPlanAdditionalInformationDetails Common Stock and Stock-Based Awards - 2022 Employment Inducement Award Plan - Additional Information (Details) Details 72 false false R73.htm 091110 - Disclosure - Common Stock and Stock-Based Awards - Summary of Stock Option Activity (Details) Sheet http://serestherapeutics.com/role/CommonStockAndStockbasedAwardsSummaryOfStockOptionActivityDetails Common Stock and Stock-Based Awards - Summary of Stock Option Activity (Details) Details 73 false false R74.htm 091112 - Disclosure - Common Stock and Stock-Based Awards - Stock Options - Additional Information (Details) Sheet http://serestherapeutics.com/role/CommonStockAndStockbasedAwardsStockOptionsAdditionalInformationDetails Common Stock and Stock-Based Awards - Stock Options - Additional Information (Details) Details 74 false false R75.htm 091114 - Disclosure - Common Stock and Stock-Based Awards - Summary of Restricted Stock Unit Activity (Details) Sheet http://serestherapeutics.com/role/CommonStockAndStockbasedAwardsSummaryOfRestrictedStockUnitActivityDetails Common Stock and Stock-Based Awards - Summary of Restricted Stock Unit Activity (Details) Details 75 false false R76.htm 091116 - Disclosure - Common Stock and Stock-Based Awards - Restricted Stock Units - Additional Information (Details) Sheet http://serestherapeutics.com/role/CommonStockAndStockbasedAwardsRestrictedStockUnitsAdditionalInformationDetails Common Stock and Stock-Based Awards - Restricted Stock Units - Additional Information (Details) Details 76 false false R77.htm 091118 - Disclosure - Common Stock and Stock-Based Awards - Summary of Estimated Fair Value of Employee Stock Options (Details) Sheet http://serestherapeutics.com/role/CommonStockAndStockbasedAwardsSummaryOfEstimatedFairValueOfEmployeeStockOptionsDetails Common Stock and Stock-Based Awards - Summary of Estimated Fair Value of Employee Stock Options (Details) Details 77 false false R78.htm 091120 - Disclosure - Common Stock and Stock-Based Awards - Summary of Stock Based Compensation Expense (Details) Sheet http://serestherapeutics.com/role/CommonStockAndStockbasedAwardsSummaryOfStockBasedCompensationExpenseDetails Common Stock and Stock-Based Awards - Summary of Stock Based Compensation Expense (Details) Details 78 false false R79.htm 091122 - Disclosure - Common Stock and Stock-Based Awards - Stock Based Compensation - Additional Information (Details) Sheet http://serestherapeutics.com/role/CommonStockAndStockbasedAwardsStockBasedCompensationAdditionalInformationDetails Common Stock and Stock-Based Awards - Stock Based Compensation - Additional Information (Details) Details 79 false false R80.htm 091200 - Disclosure - Net Loss per Share - Basic and Diluted Net Loss per Share Attributable to Common Stockholders (Details) Sheet http://serestherapeutics.com/role/NetLossPerShareBasicAndDilutedNetLossPerShareAttributableToCommonStockholdersDetails Net Loss per Share - Basic and Diluted Net Loss per Share Attributable to Common Stockholders (Details) Details 80 false false R81.htm 091300 - Disclosure - Restructuring - Additional Information (Details) Sheet http://serestherapeutics.com/role/RestructuringAdditionalInformationDetails Restructuring - Additional Information (Details) Details 81 false false R82.htm 091302 - Disclosure - Restructuring - Summary of Related Charges and Classification of Line Item in Consolidated Statements of Operations (Details) Sheet http://serestherapeutics.com/role/RestructuringSummaryOfRelatedChargesAndClassificationOfLineItemInConsolidatedStatementsOfOperationsDetails Restructuring - Summary of Related Charges and Classification of Line Item in Consolidated Statements of Operations (Details) Details 82 false false R83.htm 091304 - Disclosure - Restructuring - Schedule of Changes in Restructuring Liability (Details) Sheet http://serestherapeutics.com/role/RestructuringScheduleOfChangesInRestructuringLiabilityDetails Restructuring - Schedule of Changes in Restructuring Liability (Details) Details 83 false false R84.htm 091400 - Disclosure - Revenue from Contracts with Customers - Additional Information (Details) Sheet http://serestherapeutics.com/role/RevenueFromContractsWithCustomersAdditionalInformationDetails Revenue from Contracts with Customers - Additional Information (Details) Details 84 false false R85.htm 091402 - Disclosure - Revenue from Contracts with Customers - Changes in Contract Liabilities (Details) Sheet http://serestherapeutics.com/role/RevenueFromContractsWithCustomersChangesInContractLiabilitiesDetails Revenue from Contracts with Customers - Changes in Contract Liabilities (Details) Details 85 false false R86.htm 091404 - Disclosure - Revenue from Contracts with Customers - Schedule of Revenue Recognized (Details) Sheet http://serestherapeutics.com/role/RevenueFromContractsWithCustomersScheduleOfRevenueRecognizedDetails Revenue from Contracts with Customers - Schedule of Revenue Recognized (Details) Details 86 false false R87.htm 091500 - Disclosure - Collaboration Profit and Loss - Additional Information (Details) Sheet http://serestherapeutics.com/role/CollaborationProfitAndLossAdditionalInformationDetails Collaboration Profit and Loss - Additional Information (Details) Details 87 false false R88.htm 091502 - Disclosure - Collaboration Profit and Loss - Schedule of Collaboration Profit (Loss) (Details) Sheet http://serestherapeutics.com/role/CollaborationProfitAndLossScheduleOfCollaborationProfitLossDetails Collaboration Profit and Loss - Schedule of Collaboration Profit (Loss) (Details) Details 88 false false R89.htm 091600 - Disclosure - Commitments and Contingencies - Additional Information (Details) Sheet http://serestherapeutics.com/role/CommitmentsAndContingenciesAdditionalInformationDetails Commitments and Contingencies - Additional Information (Details) Details 89 false false R90.htm 091700 - Disclosure - Income Taxes - Additional Information (Details) Sheet http://serestherapeutics.com/role/IncomeTaxesAdditionalInformationDetails Income Taxes - Additional Information (Details) Details 90 false false R91.htm 091702 - Disclosure - Income Taxes - Schedule of Reconciliation of U.S Federal Statutory Income Tax Rate to Company's Effective Income Tax Rate (Details) Sheet http://serestherapeutics.com/role/IncomeTaxesScheduleOfReconciliationOfUSFederalStatutoryIncomeTaxRateToCompanySEffectiveIncomeTaxRateDetails Income Taxes - Schedule of Reconciliation of U.S Federal Statutory Income Tax Rate to Company's Effective Income Tax Rate (Details) Details 91 false false R92.htm 091704 - Disclosure - Income Taxes - Schedule of Net Deferred Tax Assets (Details) Sheet http://serestherapeutics.com/role/IncomeTaxesScheduleOfNetDeferredTaxAssetsDetails Income Taxes - Schedule of Net Deferred Tax Assets (Details) Details 92 false false R93.htm 091706 - Disclosure - Income Taxes - Summary of Changes In Valuation Allowance for Deferred Tax Assets (Details) Sheet http://serestherapeutics.com/role/IncomeTaxesSummaryOfChangesInValuationAllowanceForDeferredTaxAssetsDetails Income Taxes - Summary of Changes In Valuation Allowance for Deferred Tax Assets (Details) Details 93 false false R94.htm 091708 - Disclosure - Income Taxes - Schedule of Change In Unrecognized Tax Benefits Roll Forward (Details) Sheet http://serestherapeutics.com/role/IncomeTaxesScheduleOfChangeInUnrecognizedTaxBenefitsRollForwardDetails Income Taxes - Schedule of Change In Unrecognized Tax Benefits Roll Forward (Details) Details 94 false false R95.htm 091800 - Disclosure - Related Party Transactions - Additional Information (Details) Sheet http://serestherapeutics.com/role/RelatedPartyTransactionsAdditionalInformationDetails Related Party Transactions - Additional Information (Details) Details 95 false false R96.htm 091900 - Disclosure - 401(k) Savings Plan - Additional Information (Details) Sheet http://serestherapeutics.com/role/KSavingsPlanAdditionalInformationDetails 401(k) Savings Plan - Additional Information (Details) Details 96 false false All Reports Book All Reports mcrb-20240815.xsd mcrb-20240815_cal.xml mcrb-20240815_def.xml mcrb-20240815_lab.xml mcrb-20240815_pre.xml ny20030749x9_8k.htm ny20030749x9_ex99-1.htm http://fasb.org/us-gaap/2023 http://xbrl.sec.gov/dei/2023 true true